Afya Shares Sink as Merger Plan Forces Nasdaq Exit for Brazil’s B3

Afya Limited, one of Brazil’s largest medical education groups, saw its shares on the Nasdaq stock exchange drop 5.23% today, trading at $12.32, as investors reacted negatively to a planned merger that will result in the company’s U.S. listing being terminated. The sharp decline continues a period of volatility for Afya (AFYA) after it announced last week a binding merger agreement with its major rival, Yduqs Participações S.A., which is a much broader Brazilian higher-education provider.

The decline reflects concern among US investors about the structure of the deal, which will merge Afya into Yduqs and combine the two into a massive education group serving approximately 1.6 million students with pro-forma annual revenues of R$9.4 billion. While the creation of an education powerhouse is seen as strategically positive, the definitive agreements specify that the combined company’s shares will be listed solely on the B3 exchange in São Paulo, under its demanding Novo Mercado segment.

For many American retail investors, Afya's shares are unique because they trade directly on the Nasdaq, unlike most large Brazilian firms that are accessible only via an American Depositary Receipt (ADR). This planned shift means the direct path to ownership for Afya shareholders is set to close. Under the proposed terms, each Afya share will be exchanged for 6.408347 newly issued Yduqs shares. However, for many smaller or ineligible U.S. shareholders, the merger agreement stipulates they will not receive Brazilian-listed shares directly; instead, their shares will be sold on the B3 after closing, and they will receive net cash proceeds.

The immediate pressure on the stock comes from the complex process of converting a Nasdaq-listed equity into a security listed only in Brazil. The uncertainty surrounding the future listing venue, the mechanics of the conversion, and the potential tax implications are fueling investor caution. Consequently, the shares are facing pressure as some investors opt to exit the stock rather than navigate the complexities of a required delisting and conversion into a foreign-listed security. The merger still requires approvals from both Afya and Yduqs shareholders, as well as clearance from the Brazilian antitrust authority, CADE.

What it touches: Afya Limited (AFYA) is the primary asset affected, alongside its merger partner Yduqs, which trades on Brazil’s B3 exchange under the ticker YDUQ3. The ongoing volatility highlights the transactional risks for foreign investors in the Brazilian education sector, which has attracted significant capital due to high domestic demand for specialized university education.